Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
IPO Year:
Exchange: NYSE
Website: centene.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/17/2024 | $80.00 → $75.00 | Overweight | Analyst |
12/13/2024 | $79.00 → $80.00 | Neutral → Buy | UBS |
12/10/2024 | $68.00 → $52.00 | Hold → Underperform | Jefferies |
7/24/2024 | $83.00 → $69.00 | Buy → Hold | Jefferies |
5/30/2024 | $83.00 | Neutral | Robert W. Baird |
3/21/2024 | $92.00 → $85.00 | Overweight → Equal-Weight | Stephens |
3/6/2024 | $101.00 | Overweight | Barclays |
1/2/2024 | $82.00 → $90.00 | Equal Weight → Overweight | Wells Fargo |
8/30/2023 | $94.00 → $73.00 | Overweight → Equal-Weight | Morgan Stanley |
7/12/2023 | Outperform → Peer Perform | Wolfe Research |
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
4 - CENTENE CORP (0001071739) (Issuer)
Analyst resumed coverage of Centene with a rating of Overweight and set a new price target of $75.00 from $80.00 previously
UBS upgraded Centene from Neutral to Buy and set a new price target of $80.00 from $79.00 previously
Jefferies downgraded Centene from Hold to Underperform and set a new price target of $52.00 from $68.00 previously
Jefferies downgraded Centene from Buy to Hold and set a new price target of $69.00 from $83.00 previously
Robert W. Baird initiated coverage of Centene with a rating of Neutral and set a new price target of $83.00
Stephens downgraded Centene from Overweight to Equal-Weight and set a new price target of $85.00 from $92.00 previously
Barclays initiated coverage of Centene with a rating of Overweight and set a new price target of $101.00
Wells Fargo upgraded Centene from Equal Weight to Overweight and set a new price target of $90.00 from $82.00 previously
Morgan Stanley downgraded Centene from Overweight to Equal-Weight and set a new price target of $73.00 from $94.00 previously
Wolfe Research downgraded Centene from Outperform to Peer Perform
ST. LOUIS, Jan. 15, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Tuesday, February 4, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, unde
First-of-its-kind health plan and housing agency partnership in Hawaii offers transitional housing and structured support for its most vulnerable members experiencing homelessness HILO, Hawaii, Jan. 14, 2025 /PRNewswire/ -- 'Ohana Health Plan, a leading provider of government-sponsored managed care services in Hawaii and a Centene Corporation company (NYSE:CNC), in partnership with Hope Services Hawaii, Hawaii Island's largest nonprofit homeless services provider, held a grand opening and blessing for a brand-new residential program for integrated clinical care. The program addresses a critical gap in housing support for 'Ohana's highest acuity members experiencing homelessness, who also hav
ALBANY, N.Y., Jan. 13, 2025 /PRNewswire/ -- Fidelis Care, a statewide health plan with more than 2.4 million members in New York State and a wholly owned subsidiary of Centene Corporation (NYSC: CNC), is pleased to announce a coverage area expansion of the Essential Plan into Clinton County, starting January 1, 2025. The Essential Plan aims to bridge the gap for those who may not qualify for Medicaid Managed Care but still need access to quality, low-cost health insurance. The Essential Plan is available to eligible residents, whose income is up to 250 percent of the Federal
New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan
Health Net Assisting Members During State of Emergency SACRAMENTO, Calif., Jan. 8, 2025 /PRNewswire/ -- In response to Gov. Gavin Newsom's declared state of emergency in Los Angeles and Ventura Counties, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is providing special assistance to members affected by the Palisades Fire and windstorm conditions. Health Net is committed to ensuring its members have uninterrupted access to essential prescription medications, critical Health Net information and healthcare services.
MHS Serves supports the advancement of programs and innovations to improve health equity efforts statewide. INDIANAPOLIS, Jan. 7, 2025 /PRNewswire/ -- MHS Serves, a health equity program from Managed Health Services (MHS), a managed care entity that has been proudly serving the state of Indiana for over 25 years and a Centene Corporation company (NYSE:CNC), announced today the next funding opportunity for community organizations focused around youth mental health. This new partnership opportunity, Youth Mental Health Empowerment Program, will support the expansion or enhancement of current programs, services, initiatives, and resources that directly address youth access to healthcare, menta
Health Net Assisting Members During State of Emergency SACRAMENTO, Calif., Dec. 18, 2024 /PRNewswire/ -- In response to Gov. Gavin Newsom's declared state of emergency in California, Health Net, one of the state's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is providing special assistance to members affected by the Bird Flu. Health Net is committed to ensuring its members have uninterrupted access to essential prescription medications, critical Health Net information and healthcare services. Prescription Information During
The funding will help address the mental health needs of local children and youth. AUSTIN, Texas, Dec. 16, 2024 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE:CNC), announced today that National Alliance on Mental Illness (NAMI) El Paso has been awarded a $25,000 grant in recognition of Superior's 25-year anniversary celebration. The funding will be used to help support the mental health needs of children and youth in the El Paso area. "Since 1999, Superior has provided health care to
-- 2025 adjusted diluted EPS of greater than $7.25 -- -- Reaffirms 2024 adjusted diluted EPS guidance of greater than $6.80 -- ST. LOUIS, Dec. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, today will host its investor day to outline its 2025 financial guidance. "Centene is a mission driven organization, dedicated to delivering high quality outcomes for more than 28 million members, many of whom are among the nation's most medically complex and historically underserved populations. Over the last three years we improved our core operations and invested in the experience of our customer
ST. LOUIS, Dec. 5, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced that, in the wake of the tragic loss of UnitedHealthcare's CEO Brian Thompson, Centene's Investor Day will now be hosted virtually. The program will be webcast during the previously scheduled date and time – Thursday, December 12, 2024, starting at 8:30 a.m. Eastern Time. "All of us at Centene are deeply saddened by Brian Thompson's death and want to express our support for all of those affected. Health insurance is a big industry and a small community; many members of the CenTeam crossed paths with Brian during their caree
SC 13G - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
10-Q - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K/A - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
ST. LOUIS, Jan. 15, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Tuesday, February 4, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, unde
-- 2025 adjusted diluted EPS of greater than $7.25 -- -- Reaffirms 2024 adjusted diluted EPS guidance of greater than $6.80 -- ST. LOUIS, Dec. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, today will host its investor day to outline its 2025 financial guidance. "Centene is a mission driven organization, dedicated to delivering high quality outcomes for more than 28 million members, many of whom are among the nation's most medically complex and historically underserved populations. Over the last three years we improved our core operations and invested in the experience of our customer
-- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $1.62 in the third quarter of 2024.Premium and service revenues of $36.9 billion in the third quarter of 2024.Membership increases of 22% in Marketplace and 49% in Medicare Prescription Drug Plans, compared to the third quarter of 2023.Continued execution on capital deployment with $1.2 billion of share repurchases during the third quarter of 2024 and an additional $380 million in October, bringing full-year repurchases to $2.4 billion through October 2024.ST. LOUIS, Oct. 25, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the
ST. LOUIS, Oct. 8, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 third quarter financial results at approximately 6:00 a.m. ET on Friday, October 25, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1267976 to expedite
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.42 ---- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $2.42, up 15% from $2.10 in the second quarter of 2023.Premium and service revenues of $36.0 billion in the second quarter of 2024.Membership increase of 34% in Marketplace, compared to the second quarter of 2023.ST. LOUIS, July 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the second quarter ended June 30, 2024. In summary, the 2024 second quarter results were as follows: Total revenues (in millions) $ 39,836 Premium and service revenues (in millions) $
ST. LOUIS, July 2, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 26, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 4980577 to expedite c
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to greater than $6.80.Premium and service revenues of $36.3 billion in the first quarter of 2024. Increases 2024 full year premium and service revenue guidance by $1.0 billion.Membership increase of 41% in Marketplace, compared to the first quarter of 2023.ST. LOUIS, April 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the first quarter ended March 31, 2024. In summary, the 2024 fir
ST. LOUIS, March 7, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 first quarter financial results at approximately 6 a.m. ET on Friday, April 26, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9229812, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors sec
-- 2023 Full Year Diluted EPS of $4.95; Adjusted Diluted EPS of $6.68 -- 2023 adjusted diluted EPS of $6.68, up over 15% from $5.78 in 2022.2023 health benefits ratio of 87.7%, consistent with 2022.Executed on capital deployment with $1.6 billion of share repurchases in 2023.Successful portfolio review execution, completing the final two international divestitures in the past two months: Circle Health and Operose Health. Increased 2024 premium and service revenues guidance by $2.5 billion.ST. LOUIS, Feb. 6, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December 31, 2023. In summary, the 2023 fou
ST. LOUIS, Jan. 23, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) issued a reminder today that it will release its 2023 fourth quarter and full year financial results at approximately 6 a.m. ET on Tuesday, February 6, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 3061147, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section. A webcast replay will be available for on-demand l
New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan
PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE:CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She most recently served as Sunshine Health Chief Product President, where she had oversight of all of Sunshine Health's Medi
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE:CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman. Centene, a leading healthcare enterprise focused on transforming the health of the communities it serves, has been a long-time partner of BBBSA. Dinesman oversees Federal and State Government Relations; Centene's political action committee; Public Policy; Strat
Current Wellcare President & CEO, Richard Fisher, will join the Operations leadership team under Centene Chief Operating Officer Susan Smith, bringing additional Medicare expertise into Centene's core services operations ST. LOUIS, Jan. 22, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced two appointments. Michael A. Carson joins Centene as President and Chief Executive Officer (CEO) of its Medicare business, Wellcare. Mr. Carson will be responsible for Medicare business performance, strategy and growth and will report to Centene President Ken Fasola. Carson succeeds Richard Fisher, who has
PA Health & Wellness Safe & Sound Program to provide assistance with critical home repairs in Greater Harrisburg area HARRISBURG, Pa., Dec. 11, 2023 /PRNewswire/ -- PA Health & Wellness (PHW), a wholly owned subsidiary of Centene Corporation (NYSE:CNC), and Centene Foundation, the philanthropic arm of Centene Corporation, today announced its new partnership with Habitat for Humanity of the Greater Harrisburg Area to provide critical home repairs to area homeowners as part of the organization's Critical Home Repair program. The new program – PHW Safe & Sound – will cover the cost of eligible interior and exterior structural, electrical, plumbing, HVAC and other critical home repairs so that
Proctor brings more than 20 years of healthcare industry experience and proven leadership to Nebraska Total Care OMAHA, Neb., Nov. 16, 2023 /PRNewswire/ -- Nebraska Total Care, a leading provider of government-sponsored healthcare plans in Nebraska and wholly owned subsidiary of Centene Corporation (NYSE:CNC), announced today that Adam Proctor has been appointed as Plan President and Chief Executive Officer, effective November 19, 2023. Proctor replaces Heath Phillips, who was appointed to President and CEO overseeing Centene's Medicaid, Medicare and Marketplace offerings in Tennessee including Rhythm Health, Wellcare of Tennessee and Ambetter of Tennessee.
ST. LOUIS, Nov. 15, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, today announced the appointment of Susan Smith as its Chief Operating Officer (COO), effective January 1, 2024. As COO, Ms. Smith will report to Centene President Ken Fasola and will be responsible for core business operations, population health, the enterprise transformation office, provider experience and quality. She has worked at Centene since June 2023. Ms. Smith brings nearly two decades of expertise in
Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort. The first four board members include: Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund Andy Lombard, CEO of Arizona Venture Development Corporation (AVC) J
TORONTO, April 5, 2023 /PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV: CNC) (OTCQX:CNIKF) is pleased to announce the appointment of Cutfield Freeman & Co. ("Cutfield Freeman") as project debt advisors and changes to the Canada Nickel Board of Directors (the "Board"). Mark Selby, Chair and CEO said, "I am very pleased that we have engaged Cutfield Freeman, a leading global mining advisory firm, as project debt advisors. Cutfield Freeman, in conjunction with our previously appointed equity advisors, Deutsche Bank and Scotiabank, will assist t